Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status

Rheumatology International

Volumn 32, Issue 10, 2012, Pages 3143-3148

  Ibn Yacoub, Yousra ^a   Amine, Bouchra ^a   Laatiris, Assia ^a   Wafki, Fahd ^a   Znat, Fatima ^a   Hajjaj Hassouni, Najia ^a  

^a Hopital El Ayachi   (Morocco)

Author keywords

Bone mineral density; Disease activity; Systemic sclerosis; Vitamin D

Indexed keywords

CALCIFEDIOL; DNA TOPOISOMERASE INHIBITOR;

ADULT; AGED; ARTHRALGIA; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FAMILY HISTORY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALABSORPTION; MENOPAUSE; MOROCCO; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; CALCIFEDIOL; CASE-CONTROL STUDIES; DISABILITY EVALUATION; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; MOROCCO; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SCLERODERMA, SYSTEMIC; TIME FACTORS; VITAMIN D DEFICIENCY;

EID: 84867896782     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2150-1     Document Type: Article

References (30)

1. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M (2007) Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol 34:1718-1726
2. Allali F, Tahiri L, Senjari A, Abouqal R, Hajjaj-Hassouni N (2007) Erosive arthropathy in systemic sclerosis. BMC Public Health 7:260
3. Loucks J, Pope JE (2005) Osteoporosis in scleroderma. Semin Arthritis Rheum 34(4):678-682
4. Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35(5):384-387
5. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, Siagri C, Chellini F, Capperucci C, Filipponi P, Galeazzi M, Marcolongo R (2004) Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 22(3):313-318
6. Pelajo CF, Lopez-Benitez JM, Miller LC (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9(7):507-510
7. Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15(14):2579-2585
8. Cutillas-Marco E, Morales-Suárez-Varela M, Marquina-Vila A, Grant W (2010) Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19(7):810-814
9. Alexandersson BT, Geirsson AJ, Olafsson I, Franzson L, Sigurdsson G, Gudbjornsson B (2007) Bone mineral density and bone turnover in systemic sclerosis. Laeknabladid 93(7-8):535-541
10. Braun-Moscovici Y, Furst DE, Markovits D, Rozin A, Clements PJ, Nahir AM, Balbir-Gurman A (2008) Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol 35(11):2201-2205
11. Masi AT and the subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90
12. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573-1576
13. Georges C, Chassany C, Mouthon L, Tiev K, Toledano C, Meyer O et al (2005) Validation of French version of the scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 24:3-10
14. Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Petaro N, Latorraca A et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407-412
15. Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23(2):180-184
16. Da Silva HC, Szejnfeld VL, Assis LS, Sato EI (1997) Study of bone density in systemic scleroderma. Rev Assoc Med Bras 43(1):40-46
17. La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin Rheumatol 10(1):18-22
18. Carbone L, Tylavsky F, Wan J, McKown K, Cheng S (1999) Bone mineral density in scleroderma. Rheumatol (Oxford) 371-372
19. Yuen SY, Rochwerg B, Ouimet J, Pope JE (2008) Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 35(6):1073-1078
20. La Montagna G, Baruffo A, Pasquali D, Bellastella A, Tirri G, Sinisi AA (2001) Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis. Rheumatol 40(3):310-314
21. Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M, Saba L, Severino A, Angeli A (2008) Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol 35(11):2206-2213
22. Lewiecki EM (2006) RANK ligand inhibition with denosumab for the management of osteoporosis. Expert Opin Biol Ther 6(10):1041-1050
23. Kim J, Park SK, Moon KW, Lee EY, Lee YJ, Song YW, Lee EB (2010) The prognostic factors of systemic sclerosis for survival among Koreans. Clin Rheumatol 29(3):297-302
24. Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I, Barausse G, Bambara LM, Biasi D (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol [Epub ahead of print]
25. Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, Bahiri R, Abouqal R, Hajjaj-Hassouni N (2009) High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum 38(6):444-451
26. Belloli L, Ughi N, Marasini B (2010) Vitamin D in systemic sclerosis. Clin Rheumatol
27. Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36(9):1924-1929
28. Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4(8):404-412
29. Van Etten E, Gysemans C, Branisteanu DD, Verstuyf A, Bouillon R, Overbergh L, Mathieu C (2007) Novel insights in the immune function of the vitamin D system: synergism with interferon-beta. J Steroid Biochem Mol Biol 103(3-5):546-551
30. Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ (1994) Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 130(10):1290-1293